Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report
Takashi Kanda, MD, Masaharu Masuda, MD, Akihiro Sunaga, MD and 8 more
Journal of Arrhythmia · 2015
doi:10.1016/j.joa.2014.10.002 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Fabry disease is an X-linked recessive glycosphingolipid storage disorder caused by a deficiency of lysosomal enzyme α-galactosidase A. It is recognized that Fabry disease patients often have ventricular arrhythmias. Although the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in patients with ventricular fibrillation is established, there is little evidence regarding ICD therapy for Fabry disease. Here, we report the case of patient with Fabry disease who was treated with an ICD and presented with high defibrillation thresholds.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.